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Bicarbonate is involved in a wide range of biological processes including 
respiration, regulation of intracellular pH and fertilization. In this study we use 
a combination of NMR and ion-selective electrode techniques to show that the 
natural product prodigiosin, a tripyrrolic molecule produced by microorganisms 
such as Streptomyces and Serratia, facilitates chloride/bicarbonate exchange 
(antiport) across liposomal membranes. Higher concentrations of simple 
synthetic molecules based on a 4,6-dihydroxyisophthalamide-core are also shown 
to facilitate this antiport process.  While it is well known that proteins regulate 
Cl-/HCO3- exchange in cells, these results suggest that small molecules may also 
be able to regulate the concentration of these anions in biological systems.  
 
 
Bicarbonate is an important anion. It is a substrate in photosynthesis,1 it regulates 
intra- and extracellular pH,2 it is generated during cellular respiration from CO2,3 and 
it acts as a cellular signal to activate sperm for fertilization.4 Under physiological 
conditions most dissolved inorganic carbon exists as HCO3-. Bicarbonate cannot 
diffuse freely across lipid membranes,5 and bicarbonate transport is facilitated in vivo 
by membrane-bound proteins that function via Cl-/HCO3- exchange or Na+/HCO3- co-
transport mechanisms.6 Dysregulation of bicarbonate transport can lead to conditions 
such as cystic fibrosis, heart disease and infertility.7-9 The lack of structural data for 
these proteins means that little is known regarding the anion binding sites that 
modulate their affinity and selectivity.8,9 Despite the importance of transmembrane 
bicarbonate transport, there have been no studies that focus attention on the use of 
"small" molecules to promote the efficient transport of bicarbonate anion across lipid 
membranes in contradistinction to the growing body of work on transmembrane 
chloride transport.10-17. Previously in a study that focused on chloride transport, a 
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synthetic steroid-based receptor was reported to support detectable Cl- efflux from 
liposomes upon addition of extravesicular HCO3-.10 The challenge of achieving 
bicarbonate transport was eloquently expressed by A. P. Davis, Sheppard and Smith 
in 2007: “A specific goal would be a mimic of chloride/bicarbonate exchangers that 
play important roles in red blood cells and epithelial tissues. The design challenge here 
is to produce a transporter that can extract the very hydrophilic bicarbonate anion into 
the lipophilic interior of a bilayer membrane.”11 
Prodigiosin 1,18 is a natural product produced by microorganisms such as 
Streptomyces and Serratia.19,20 This tripyrrolic metabolite has potent 
inmunosuppressive and anticancer activities. Prodigiosin causes selective apoptosis of 
cancer cells,21 and its structural analogue obatoclax is in clinical trials for treatment of 
cancer.22 The origin of prodigiosin’s biological activity has yet to be unambiguously 
established, although it facilitates co-transport of HCl,23-28 and anion exchange of 
chloride across lipid bilayers.29,30 Indeed, the antibiotic activity of prodigiosin-like 
compounds has been related to their activity as transmembrane Cl- carriers.28 Due to 
the presence of hydrogen bond donors and acceptors in prodigiosin 1, we reasoned 
that it might function as a receptor and a membrane transport agent for bicarbonate 
(Figure 1).   
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Figure 1. The structures of the bicarbonate transporters studied in this work: 
prodigiosin 1 (a), the putative prodigiosin bicarbonate complex (b) and the structures 
of synthetic transporters 2 – 4 (c). 
 
We also investigated the bicarbonate transport ability of 2-4 in order to ascertain 
whether these compounds function as chloride/bicarbonate antiporters, especially in 
comparison to prodigiosin 1.  We recently reported the transmembrane chloride 
transport activity of 4,6-dihydroxyisophthalamide 2.31 Isophthalamides have 
convergent amide NH groups that can form hydrogen bonds with anions.32,33 In the 
case of 2, conformational control of the anion binding cleft by intramolecular 
hydrogen bonds between the 4,6-dihydroxy units and the neighbouring amide 
carbonyls resulted in an improved anion affinity and in optimal activity for 
transmembrane transport of chloride anion.  In fact an analogue of compound 2 
lacking the OH groups was shown not to function as a membrane transport agent for 
chloride.31 For this study, we synthesized related isophthalamides 3 and 4, 
functionalized with different alkyl substituents, as we reasoned that membrane 
activity might be attenuated by the identity of the lipophilic tails attached to the 
isophthalamide (Figure 1). 
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 Phospholipid vesicles have been extensively used as models for biological 
membranes. Unilamellar vesicles of a defined size are easily produced with control of 
the entrapped solution. These liposomes can be suspended in an external medium of 
different composition and the transporter-facilitated release of encapsulated substrates 
or the influx of substances from the external milieu to the interior of the vesicles can 
be monitored by fluorescence, NMR or ion selective electrode techniques. Below, we 
report 1) the first demonstration that transmembrane chloride/bicarbonate exchange is 
facilitated by prodigiosin 1 and synthetic receptors 2-4 and 2) NMR methods to 
directly monitor the transport of bicarbonate into lipid vesicles. These NMR studies, 
in combination with the use of chloride-selective electrodes, allow the flux of both 
components of an antiport process to be monitored. We hope that these studies will 
set the stage for further development of selective transporters for bicarbonate and 
perhaps, in the longer term, lead to new approaches for treating diseases caused by 
defective bicarbonate transport. 
 
 
RESULTS 
 Prodigiosin and its analogues bind chloride in the solid-state and in 
solution.28,34 Furthermore, the use of chloride-selective dyes and electrodes revealed 
that prodigiosin 1 transports Cl- anions across lipid membranes.28,29 Although it was 
reported 50 years ago that prodigiosin reacts with carbonic acid to give a protonated 
adduct,35 there has been no direct evidence presented that prodigiosin 1 can bind 
bicarbonate. We studied the anion complexation properties of prodigiosin 1 by 1H 
NMR titration methods in CD2Cl2.  These NMR studies showed that bicarbonate 
binds to 1, causing shifts of proton resonances in prodigiosin upon addition of 
tetraethyl-ammonium bicarbonate. The NMR signals in 1 that were most affected by 
bicarbonate addition were the H2 proton on the A ring and the methyl group on the C 
ring (see Supporting Information). These would be the carbon-bound protons that 
would be expected to be most influenced by anion binding, as they are closest to 
prodigiosin’s putative anion-binding cleft (Figure 1) (the pyrrole NH protons are not 
visible in the 1H NMR of prodigiosin in the free base form in CD2Cl2). The changes in 
these chemical shifts upon addition of tetraethylammonium bicarbonate were greater 
than those for the same protons in 1 upon addition of tetrabutylammonium chloride or 
nitrate (Ka= 7.8 and 7.0 M-1, respectively), presumably reflecting the higher basicity 
of the bicarbonate anion. We could not calculate a stability constant for the 
prodigiosin-bicarbonate complex because, in addition to changes in chemical shifts 
for 1, a second set of NMR peaks emerged during bicarbonate titration.  This slow 
exchange process may be due to higher-order complex formation with bicarbonate or 
to an HCO3- triggered interconversion of rotamers.36 Experiments were repeated with 
the protonated form of prodigiosin as the methanesulfonate salt.  Under the same 
experimental conditions, addition of bicarbonate resulted in deprotonation of 1.H+ as 
evidenced by loss of the pyrrole NH resonances in the 1H NMR spectrum (see 
supplementary information), whilst addition of chloride causes a downfield shift of 
the NH resonances indicating hydrogen bond formation to the halide anion. At pH 7.2 
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both protonated and free base forms of prodigiosin are present and it may be that any 
putative antiport process involves both forms. Whilst a stability constant for 
bicarbonate complexation was not obtained, these NMR titrations demonstrated that 
the free base form of prodigiosin 1 binds bicarbonate in solution. Electrospray mass 
spectrometry in negative mode on a solution of prodigiosin 1 in acetonitrile revealed 
the presence of both chloride and bicarbonate adducts (see ESI), providing more 
evidence for complex formation between prodigiosin 1 and bicarbonate.    
We next compared the transmembrane anion transport activity of the natural 
product 1 vs. synthetic Cl- transporters 2-4. The transmembrane anion transport 
abilities of 1-4 were evaluated by monitoring chloride efflux from unilamellar POPC 
(1-palmitolyl-2-oleoyl-sn-glycero-3-phosphocholine) vesicles using a chloride 
selective electrode.10 These studies were conducted using nitrate in the extravesicular 
solution.  Nitrate is more hydrophobic than bicarbonate and is frequently used to 
assess chloride transport efficiency. Liposomes were loaded with a sodium chloride 
solution and suspended in a sodium nitrate solution. The transporters 1-4, dissolved in 
a small amount (10 µL) of DMSO, were added to the extravesicular solution and 
chloride efflux was monitored over 300 s. At the end of the experiment the vesicles 
were lysed by the addition of detergent and the final value was normalized to equal 
complete chloride efflux. Prodigiosin 1 proved to be a potent chloride transporter 
using this assay. A 0.005% molar carrier to lipid concentration of prodigiosin 1 
showed similar transport activity to the 0.1% molar carrier to lipid concentration for 
synthetic compounds 2-4 (Figure 2). These carrier loadings were capable of complete 
chloride efflux within 300 s, with the isopentyl-substituted isophthalamide 3 being the 
most active synthetic transporter under these conditions.  
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Figure 2. A comparison of chloride efflux, measured using a Cl- selective electrode, 
from synthetic vesicles mediated by compounds 1 – 4 in nitrate and sulfate solution. 
(a) Chloride efflux promoted upon addition of 1 (♦) (0.005 % molar carrier to lipid) 
and 2 (■), 3 (▲), 4 (●) (0.1 % molar carrier to lipid) to unilamellar POPC vesicles 
loaded with 488 mM NaCl 5 mM phosphate buffer pH 7.2 dispersed in 488 mM 
NaNO3 5 mM phosphate buffer pH 7.2. At t = 300 s the vesicles were lysed by 
addition of detergent and the final reading at t = 420 s was considered to equal 100% 
chloride efflux. (b) Chloride efflux studies upon addition of compounds 1 (0.04 % 
molar carrier to lipid) and 2-4 (0.5 % molar carrier to lipid) to vesicles composed of 
POPC. The vesicles contained NaCl (488 mM) and were immersed in Na2SO4 (166 
mM), pH 7.2 solution; at 300 s the vesicles were lysed to obtain 100% chloride efflux. 
 
In the assay depicted in Figure 2a, the anion transport activity can occur either via 
H+/Cl- or Na+/Cl- co-transport or by Cl-/NO3- exchange. To distinguish between these 
alternative mechanisms, we carried out the Cl- electrode transport assay while varying 
the anion in the external medium. If transport occurs by an anion exchange 
mechanism, changing the external anion should impact the transport rate, whilst a 
H+/Cl- or Na+/Cl- co-transport mechanism should not be affected by the external 
anion. As depicted in Figure 2b, the transport assay was repeated by suspending the 
chloride-loaded vesicles in a sulfate-containing external medium. As the sulfate 
dianion carries a higher charge and is significantly more hydrophilic than nitrate, 
transport activity by compounds 1-4 should be reduced if an anion exchange 
mechanism is operative. Indeed, with sulfate as the external anion, no chloride efflux 
from the liposomes was detected upon addition of 1-4, supporting a chloride/nitrate 
exchange (antiport) mechanism for mediating anion transport across the vesicle 
bilayer.  
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While both nitrate and bicarbonate have similar sizes and shapes, bicarbonate 
is significantly more hydrated than nitrate and, as stressed by A. P. Davis et al,11 it is 
more challenging to transport bicarbonate than nitrate across a lipid bilayer.37,38 
Prompted by the ability of prodigiosin 1 to bind bicarbonate and by the Cl-/NO3- 
anion exchange activity shown by 1-4, we designed an experiment to determine 
whether these compounds could facilitate transmembrane bicarbonate/chloride 
exchange. Chloride-loaded vesicles were suspended in a sulfate-containing medium. 
After 2 minutes, a solution of bicarbonate was added and chloride efflux was 
monitored over an additional 5 minutes. At the end of the experiment the vesicles 
were lysed to calibrate the experimental data to 100% chloride release. The results 
shown in Figure 3 confirmed that negligible chloride efflux was detected in the 
presence of sulfate as the external anion. Addition of bicarbonate to the extravesicular 
solution switched on chloride efflux in the presence of 1-4, indicating that these 
compounds enable chloride/bicarbonate antiport across liposomal membranes. As was 
observed for Cl-/NO3- exchange, prodigiosin 1 (at 0.04 % molar carrier to lipid) was 
more efficient than synthetic carriers 2-4 (1 % molar carrier to lipid) in catalyzing Cl-
/HCO3- transmembrane exchange.  
 
 
 
 
Figure 3. An experiment showing chloride transport measured using a Cl- selective 
electrode commencing upon addition of a bicarbonate pulse to the external solution. 
(a) i) Chloride efflux promoted upon addition of 1 (♦) (0.04 % molar carrier to lipid) 
and 2 (■), 3 (▲), 4 (●) (1 % molar carrier to lipid) to unilamellar POPC vesicles 
loaded with 451 mM NaCl and 20 mM phosphate buffer pH 7.2 dispersed in 150 mM 
Na2SO4 20 mM phosphate buffer pH 7.2. ii) At t = 120 s a solution of NaHCO3 was 
added to give a 40 mM external concentration. At t = 420 s the vesicles were lysed by 
addition of detergent and the final reading at t = 540 s was considered to equal 100% 
chloride efflux. (b) In the presence of the carrier compounds 1-4 chloride was not 
released from the vesicles when suspended in a sulfate solution. (c) Upon introduction 
of bicarbonate to the solution, chloride efflux began as one component of the 
chloride/bicarbonate antiport mechanism. 
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Under the above assay conditions, addition of bicarbonate induced small 
changes (~0.2 units) in the pH of the external medium. We carried out control 
experiments in the presence of compounds 1-4 to rule out the possibility that chloride 
efflux was driven by a pH gradient. Addition of NaOH to the external medium 
resulted in no significant chloride efflux. Furthermore, addition of bicarbonate 
solutions to a suspension of vesicles without the presence of transporters 1-4 resulted 
in no chloride efflux. 
The experiments depicted in Fig. 3 provided strong, yet indirect, evidence that 
transporters 1-4 move bicarbonate across lipid membranes. We next used 13C NMR 
spectroscopy to verify that transporters 1-4 facilitate transmembrane HCO3-/Cl- 
exchange. We developed experiments that use paramagnetic Mn2+ to bleach the 13C 
NMR signal for extravesicular H13CO3-, allowing for discrimination of extravesicular 
and intravesicular H13CO3-. We based these paramagnetic NMR protocols on previous 
experiments that 1) monitored transmembrane chloride transport in liposomes by 35Cl 
NMR,39,40 and 2) showed that intracellular and extracellular H13CO3- could be 
distinguished in plant cells.41,42 Figure 4 shows data from the first set of NMR 
experiments conducted to illustrate transporter-mediated HCO3-/Cl- exchange. These 
NMR experiments were done under similar conditions as described for the Cl- 
electrode experiments in Figure 3. Thus, EYPC liposomes (5 µm) filled with 450 mM 
NaCl were suspended in a sulfate solution and 50 mM H13CO3- was added to the 
NMR sample. A sharp 13C NMR signal for extravesicular H13CO3- was observed at δ 
161 ppm. Upon addition of 0.5 mM Mn2+, this signal was broadened into the baseline 
as the paramagnetic cation interacted with extravesicular bicarbonate. After addition 
of transporters (prodigiosin 1 in Figure 4b and isophthalamide 4 in Figure 4c), a sharp 
13C NMR signal for H13CO3- (δ ~161 ppm) was restored. This renewed 13C NMR 
signal must be caused by ligand-mediated transport of HCO3- into the liposome since 
the paramagnetic Mn2+ is impermeable to the phospholipid bilayer. Importantly, the 
control experiment in which DMSO was added without transporter, did not result in 
any restoration of 13C NMR signal (Figure 4d).  
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Figure 4. Carbon-13 NMR experiments demonstrate that both natural products and 
synthetic receptors are capable of chloride/bicarbonate antiport by allowing 
bicarbonate to enter the vesicles as shown by the HCO3- 13C NMR resonance 
reappearing in the presence of paramagnetic MnCl2 in the external solution. (a) A 
representation of titration sequence and 13C NMR data (b-d) for monitoring 
transmembrane transport of HCO3- into Cl--loaded EYPC liposomes by 1 and 4: i) a 
NaH13CO3 pulse (50 mM) was added to EYPC vesicles loaded with 450 mM NaCl, 
20 mM HEPES (pH 7.3) and dispersed in 150 mM Na2SO4, 20 mM HEPES (pH 7.3); 
ii) NMR spectra after addition of 0.5 mM Mn2+ (1:100 Mn2+/H13CO3- ratio); iii) NMR 
spectra after addition of transporter or DMSO (1 – 0.1 mol %, 4 – 1 mol % relative to 
lipid, or DMSO – 403 mol%).  
 
Figure 5 shows data from another NMR experiment designed to verify transporter-
mediated HCO3-/Cl- exchange. In these experiments we monitored bicarbonate efflux 
from vesicles loaded with H13CO3- upon addition of transporters 1 or 4. Thus, EYPC 
vesicles filled with H13CO3- and suspended in Na2SO4 solution were aged overnight at 
4 ºC. Two 13C NMR signals separated by 1 ppm (δ ~162 and ~161 ppm) were 
observed, corresponding to separate signals for intravesicular and extravesicular 
H13CO3- (Figure 5b-d). No leakage of H13CO3- from these vesicles occurred after 
addition of 50 mM NaCl. A DMSO solution of the transporters was then added to 
give ligand-to-lipid ratios of 0.1 mol % for 1 or 1 mol % for 4.  These transporters 
promote Cl-/H13CO3- exchange, as confirmed by observation of only the NMR signal 
for extravesicular H13CO3- (Figure 5b/c). After addition of 0.5 mM Mn2+ (1:100 Mn2+/ 
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H13CO3-), this H13CO3- signal was broadened into the baseline, confirming that all of 
the intravesicular H13CO3- ions had been exchanged into the extravesicular milieu 
(Figure 5b/c). A control experiment confirmed this interpretation (Figure 5d). Thus, 
after addition of DMSO, the separate signals for intravesicular and extravesicular 
H13CO3 remained unchanged. Addition of Mn2+ to this control sample erased the 
extravesicular H13CO3- signal, whereas the intravesicular H13CO3- signal remained 
intact since Mn2+ cannot cross the lipid membrane.  
 
 
 
 
 
 
Figure 5. Carbon-13 NMR experiments demonstrate that both natural products and 
synthetic receptors are capable of chloride/bicarbonate antiport by releasing 
encapsulated bicarbonate as evidenced by the HCO3- 13C resonance disappearing in 
the presence of paramagnetic MnCl2 in the external solution. Representation of the 
titration sequence (a) and NMR stack plots (b-d) for monitoring the transmembrane 
transport of HCO3- ions in H13CO3--loaded EYPC liposomes by 1 and 4. A 50 mM 
NaCl pulse was added to EYPC vesicles loaded with 100 mM NaH13CO3, 20 mM 
HEPES buffer (pH 7.5) and dispersed in 75 mM Na2SO4, 20 mM HEPES buffer (pH 
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7.3), and 13C-NMR data was acquired before (i) and after (ii) the Cl- pulse. NMR 
spectra were also collected after the addition of transporter or DMSO (1 – 0.1 mol%, 
4 – 1 mol%, or DMSO – 870 mol% (10 µL); iii), followed by addition of 0.5 mM 
Mn2+ (1:100 Mn2+/Cl- ratio; iv).  
 
DISCUSSION 
 
This work identifies “small” molecules that function as transmembrane 
bicarbonate carriers. The ion selective electrode assays showed that both prodigiosin 
1 and synthetic isophthalamides 2-4 facilitate the release of encapsulated chloride 
from POPC phospholipid liposomes in the presence of trigonal planar oxoanions such 
as nitrate and bicarbonate. This efflux is produced via an exchange mechanism with 
external nitrate or bicarbonate anions.29,31 Replacing nitrate with sulfate in the 
external medium resulted in no anion transport activity, as an anion exchange 
mechanism is not possible due to sulfate’s hydrophilicity. An assay in which 
bicarbonate was added to the external sulfate medium showed that chloride transport 
mediated by 1-4 was restored, evidence that these compounds can extract the 
hydrophilic bicarbonate from aqueous solution into the interior of the phospholipid 
membrane, thus facilitating transmembrane HCO3-/Cl- exchange. The 13C NMR 
assays provided direct evidence for transmembrane bicarbonate transport, as the intra- 
and extra-vesicular 13C-labelled bicarbonate populations could be distinguished. This 
NMR data, when combined with results from the Cl--selective electrode experiments, 
firmly establish that compounds 1-4 enable the transmembrane exchange of Cl-
/HCO3- anions. 
In conclusion, we have demonstrated that “small” molecules, including the 
natural product prodigiosin 1 and synthetic transporters 2-4, facilitate the 
chloride/bicarbonate exchange process that is typically mediated by membrane 
proteins. This is the first report that prodigiosin 1 can catalyze chloride/bicarbonate 
antiport. This discovery may well present an alternative mechanism by which 
prodigiosin 1 can influence biological systems. Furthermore, prodigiosin 1 is more 
efficient at catalyzing Cl-/HCO3- exchange than are synthetic isophthalamides 2-4, 
suggesting that the tripyrrole unit with its array of hydrogen bonding donor and 
acceptor groups may be an excellent motif on which to base the synthesis of potent 
bicarbonate receptors and transporters. Such synthetic bicarbonate/chloride 
antiporters may prove to be useful tools for biomembrane research. Efforts aimed at 
producing improved and selective bicarbonate transporters and the investigation of 
their biological activity are underway in our laboratories. 
 
METHODS 
 
Preparation of Phospholipid Vesicles. A chloroform solution of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) (20 mg/mL) (Genzyme) was evaporated  
in vacuo using a rotary evaporator and the lipid film obtained was dried under high 
vacuum for at least 2 hours. The lipid film was rehydrated by addition of a sodium 
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chloride solution (488 mM NaCl and 5 mM phosphate buffer, pH 7.2 or 451 mM 
NaCl and 20 mM phosphate buffer, pH 7.2) and followed by careful vortexing. The 
lipid suspension was then subjected to 9 freeze-thaw cycles and 29 extrusions through 
a 200 nm polycarbonate Nucleopore membrane using a LiposoFast Basic extruder 
(Avestin, Inc.) to obtain unilamellar vesicles. The vesicles were dialyzed against a 
NaNO3 solution (488 mM NaNO3 and 5 mM phosphate buffer, pH 7.2) or Na2SO4 
solution (150 mM Na2SO4 and 20 mM phosphate buffer, pH 7.2) to remove 
unencapsulated NaCl. 
 
ISE Transport Assays. Unilamellar vesicles (200 nm mean diameter) composed of 
POPC containing an encapsulated solution of 488 mM NaCl and 5 mM phosphate 
buffer pH 7.2 or 451 mM NaCl and 20 mM phosphate buffer pH 7.2, were suspended 
in a solution of 488 mM NaNO3 and 5 mM phosphate buffer pH 7.2, or 150 mM 
Na2SO4 and 20 m M phosphate buffer pH 7.2, for a final lipid concentration of 1 mM. 
A DMSO solution of the carrier molecule, typically 10 µL to avoid influence of the 
solvent molecules in the assay, was added and the chloride release from vesicles was 
monitored using an Accumet chloride selective electrode for 7 minutes. At a time (t) = 
5 min the vesicles were lysed with detergent (polyoxyethylene (8) lauryl ether) to 
release all chloride ions; the resulting value was considered to represent 100% release 
and used as such. 
 
For the anion exchange assays in the vesicles suspended in a Na2SO4 solution a 
solution of NaHCO3 or NaNO3 was added for a final concentration of 40 mM at t = 2 
min. The chloride efflux was monitored for another 5 minutes and at a time (t) = 7 
min the vesicles were lysed with detergent (polyoxyethylene (8) lauryl ether) to 
release all chloride ions; the resulting value was considered to represent 100% release 
and used as such. 
 
13C NMR Assays  
Materials. 13C NMR spectra were recorded on a Bruker DRX500 instrument 
operating at 125.77 MHz, with chemical shifts reported in ppm. Egg yolk 
phosphatidylcholine (EYPC) lipids, nuclepore® polycarbonate membranes and 
membrane filters were purchased from Avanti Polar Lipids. Deuterated solvents were 
purchased from Cambridge Isotope Laboratories. Prodigiosin was a gift from the 
Development Theraputics Program at the National Cancer Institute, U. S. National 
Institutes of Health. All other chemicals were purchased from Sigma, Aldrich, Fisher, 
Fluka, or Acros and used without further purification. 
 
Liposome Preparation for 13C NMR Assays. Giant EYPC liposomes (5 µm) were 
prepared by evaporating a chloroform solution of EYPC (20 mg/mL) under reduced 
pressure, resulting in a thin film that was dried in vacuo overnight.  The liposomes 
were then formed by rehydrating the lipid film with either 450 mM NaCl in 20 mM 
HEPES (pH 7.3) buffer (for the liposomes described in Figure 4 of main text, i.e., the 
Cl--loaded liposomes), or 100 mM NaH13CO3 in 20 mM HEPES (pH 7.5) buffer (for 
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the liposomes described in Figure 5, i.e., the HCO3--loaded liposomes).  Buffer 
solutions were prepared in a 9:1 H2O/D2O mixture.  After 5 freeze/thaw cycles, the 
liposomes were extruded through a 5 µm polycarbonate membrane 41 times at room 
temperature using a high-pressure mini-extruder (Avanti). For the Cl--loaded 
liposomes, the giant liposome suspension obtained after extrusion was used without 
further purification in the 13C NMR transport assays. However, for the HCO3--loaded 
liposomes, the resulting giant liposome suspension was separated from extravesicular 
NaH13CO3 by size exclusion chromatography (SEC) (stationary phase: Sephadex G-
25, mobile phase: 9:1 H2O/D2O, 20 mM HEPES, pH 7.3, 75 mM Na2SO4).  The 30 
mL suspension (NaH13CO3 inside, Na2SO4 outside) collected was centrifuged 
(Eppendorf Centrifuge 5804R) at 10,000 rpm for 30 minutes followed by the removal 
of the non-liposome containing buffer. The recovered giant liposome suspension was 
then diluted with the 75 mM Na2SO4 mobile phase buffer and used directly in the 13C 
NMR transport assays. The stock concentrations obtained for the liposomes were 90.3 
mM for the Cl--loaded liposomes (assuming 100% lipid retention after extrusion) and 
66.6 mM for the HCO3--loaded liposomes (assuming 80% lipid retention after gel 
filtration) respectively. 
 
Bicarbonate Transport in Cl--Loaded Liposomes Monitored by 13C NMR. 13C 
NMR spectra were recorded using a Bruker DRX500 spectrometer with a 5 mm broad 
band probe operating at 125.77 MHz, with chemical shifts reported in ppm.  The 
instrument was locked on 9:1 H2O/D2O.  Experimental conditions were: acquisition 
time, 0.93 s; spectrum width, 35211 Hz; 90º pulse width, 6.70 µs; relaxation delay, 
0.2 s; number of scans, 160; temperature, 27 ºC.  For each experiment, 230 µL of 
stock (90.3 mM) liposome solution was mixed with 340 µL of 150 mM Na2SO4 in 20 
mM HEPES (pH 7.3) buffer in a 5 mm NMR tube to give a liposome suspension 
containing NaCl inside, and Na2SO4 outside. A NaH13CO3 pulse was then added to 
the mixture to give 35 mM and 50 mM final concentrations of liposome and H13CO3- 
respectively.  The 13C NMR of the preceding liposome mixture (NaCl inside, Na2SO4 
and NaH13CO3 outside) was then taken. After data acquisition, a solution of MnCl2 
was added to give a final Mn2+ concentration of 0.5 mM (1:100 Mn2+/H13CO3- ratio), 
and immediately followed by another set of data acquisition.  Finally, a final set of 
13C NMR data was collected after the addition of a solution of the ligand (1 or 4) or 
DMSO to the mixture.  Isophthalamide 4 was added in a 1 mol% ligand-to-lipid ratio, 
while prodigiosin 1 was added in a 0.1 mol% ligand-to-lipid ratio. For the DMSO 
control, 6 µL of the solvent was added corresponding to a 403 mol% DMSO-to-lipid 
ratio.  
 
Bicarbonate Transport in HCO3--Loaded Liposomes Monitored by 13C NMR. 
Instrument details are the same as described above for the Cl--loaded liposomes. The 
instrument was locked on 9:1 H2O/D2O.  Experimental conditions were: acquisition 
time, 0.93 s; spectrum width, 35211 Hz; 90º pulse width, 6.70 µs; relaxation delay, 
0.2 s; number of scans, 196; temperature, 27 ºC.  For each experiment, an initial 13C 
NMR spectrum of 520 µL of the giant liposome solution was acquired. Then, a NaCl 
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pulse resulting in final extravesicular concentrations of 58 mM and 50 mM for the 
giant liposomes and Cl- respectively was added to the NMR tube.  The 13C NMR of 
the preceding liposome mixture (NaH13CO3 inside, Na2SO4 and NaCl outside) was 
taken followed by the addition of a solution of the ligand (1 or 4) or DMSO to the 
cocktail.  Again, isophthalamide 4 was added in a 1 mol% ligand-to-lipid ratio, while 
prodigiosin 1 was added in a 0.1 mol% ligand-to-lipid ratio. For the DMSO control, 
10 µL of the solvent was added corresponding to an 870 mol% DMSO-to-lipid ratio. 
A 13C NMR spectrum of the ligand-containing cocktail was then acquired before and 
after the addition of a solution of MnCl2 (0.5 mM final Mn2+ concentration 
corresponding to 1:100 Mn2+/Cl- ratio).  
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